Dynavax finishes 2,400-patient hepatitis vaccine test
Dynavax finishes 2,400-patient hepatitis vaccine test Bizjournals.com
View ArticleTeva Faces Second Trial Over Hepatitis Cases Linked to Drug
Teva Faces Second Trial Over Hepatitis Cases Linked to Drug Bloomberg
View ArticleTeva Not Responsible for Nevada Hepatitis Outbreak, Lawyer Tells Jurors
Teva Not Responsible for Nevada Hepatitis Outbreak, Lawyer Tells Jurors Bloomberg
View ArticleInhibitex Auction Shows Battle for Hepatitis Drugs
Inhibitex Auction Shows Battle for Hepatitis Drugs Minyanville
View ArticleOraSure Technologies Announces Rapid HCV Testing Initiatives for First...
OraSure Technologies Announces Rapid HCV Testing Initiatives for First National Hepatitis Testing Day Yahoo/GlobeNewswire
View ArticleAethlon Medical Announces Expanded Access to Hemopurifier® Therapy For...
Aethlon Medical Announces Expanded Access to Hemopurifier® Therapy For Individuals Infected with Hepatitis C Virus (HCV) Yahoo/PRNewswire
View ArticleOraSure Technologies Applauds New CDC Recommendations That All Baby Boomers...
OraSure Technologies Applauds New CDC Recommendations That All Baby Boomers be Tested for Hepatitis C Yahoo/GlobeNewswire
View ArticleGilead-Bristol Hepatitis C Drug Combo Cures 100% in Study
Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study Bloomberg
View ArticleIdenix Pharma Initiates Phase II Study
Idenix Pharma Initiates Phase II Study Yahoo/Zacks
View ArticleGilead Announces U.S. FDA Priority Review Designation for Sofosbuvir for the...
Gilead Announces U.S. FDA Priority Review Designation for Sofosbuvir for the Treatment of Hepatitis C Yahoo/BusinessWire
View ArticleThree Future Winners and One Major Loser in the HCV Wars
Three Future Winners and One Major Loser in the HCV Wars Motley Fool
View ArticleVertex Says U.S. Places Partial Hold on Hepatitis Study
Vertex Says U.S. Places Partial Hold on Hepatitis Study Bloomberg
View ArticleWhy Idenix Could Rise Even Higher, and Challenge Gilead and Vertex
Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex Yahoo/24-7 Wallstreet
View ArticleMerck Announces Presentation of Interim Data from Study of Investigational...
Merck Announces Presentation of Interim Data from Study of Investigational Combination of HCV Therapies MK-5172 and MK-8742 at the 2013 American Association for the Study of Liver Diseases (AASLD)...
View ArticleBristol seeks Japan approval of all-oral hepatitis C treatment
Bristol seeks Japan approval of all-oral hepatitis C treatment Yahoo/Reuters
View ArticleGilead Sciences and Johnson & Johnson Push Vertex Out of Hepatitis C Race
Gilead Sciences and Johnson & Johnson Push Vertex Out of Hepatitis C Race Motley Fool
View ArticleNew GT-1b Data from ABT-450 Containing Regimen Being Presented at The Liver...
New GT-1b Data from ABT-450 Containing Regimen Being Presented at The Liver Meeting Yahoo/BusinessWire
View ArticleJ&J, Medivir Win U.S. FDA Approval for Hepatitis C Pill
J&J, Medivir Win U.S. FDA Approval for Hepatitis C Pill Bloomberg
View ArticleGilead And AbbVie Battle For Top Spot In $20 Billion Hepatitis Drug Market
Gilead And AbbVie Battle For Top Spot In $20 Billion Hepatitis Drug Market Seeking Alpha
View Article
More Pages to Explore .....